Catalog No.:AA000GCG

115204-76-7 | Benzonitrile, 4-[(2,6-dichloro-9H-purin-9-yl)methyl]-

Name: Name:Benzonitrile, 4-[(2,6-dichloro-9H-purin-9-yl)methyl]-
Brand: AABLOCKS
SKU: AA000GCG
Availability: InStock
Rating: 90 (10 reviews)

Pack Size

Purity

Availability

Price(USD)

Quantity

50mg

95%

1 week

$110.00 $77.00

- +

100mg

95%

1 week

$175.00 $123.00

- +

250mg

95%

1 week

$283.00 $198.00

- +

Technical Information
Properties
Downstream Synthesis Route
Literature
Request for Quotation
Download SDS

Technical Information
Properties
Downstream Synthesis Route
Literature

Technical Information

Catalog Number:

AA000GCG

Chemical Name:

Benzonitrile, 4-[(2,6-dichloro-9H-purin-9-yl)methyl]-

CAS Number:

115204-76-7

Molecular Formula:

C13H7Cl2N5

Molecular Weight:

304.1342

MDL Number:

MFCD31696585

SMILES:

N#Cc1ccc(cc1)Cn1cnc2c1nc(Cl)nc2Cl

Properties

Downstream Synthesis Route

124-40-3

115204-76-7

115204-61-0

[1]Kelley,JamesL.;Linn,JamesA.;Krochmal,MarkP.;Selway,J.W.T.[JournalofMedicinalChemistry,1988,vol.31,#10,p.2001-2004]

5451-40-1

17201-43-3

115204-76-7

[1]Gadd,AdamJ.R.;Castelletto,Valeria;Kabova,Elena;Shankland,Kenneth;Perrie,Yvonne;Hamley,Ian;Cobb,AlexanderJ.A.;Greco;Edwards,AlexanderD.[EuropeanJournalofPharmaceuticalSciences,2018,vol.123,p.268-276]

[2]CurrentPatentAssignee:UNIVERSITYOFCALIFORNIA-WO2007/24707,2007,A2Locationinpatent:Page/Pagecolumn18;24

[3]CurrentPatentAssignee:TORQUETHERAPEUTICS-WO2020/23680,2020,A1Locationinpatent:Page/Pagecolumn13;78;123

[4]Szekely,Thomas;Roy,Olivier;Dériaud,Edith;Job,Aurélie;Lo-Man,Richard;Leclerc,Claude;Taillefumier,Claude[JournalofMedicinalChemistry,2018,vol.61,#21,p.9568-9582]

[5]Kelley,JamesL.;Linn,JamesA.;Krochmal,MarkP.;Selway,J.W.T.[JournalofMedicinalChemistry,1988,vol.31,#10,p.2001-2004]

[6]CurrentPatentAssignee:UROGENPHARMALTD-US9173936,2015,B2Locationinpatent:Page/Pagecolumn36;39

115204-76-7

927822-40-0

[1]EuropeanJournalofPharmaceuticalSciences,2018,vol.123,p.268-276

[2]JournalofMedicinalChemistry,2018,vol.61,p.9568-9582

[3]Patent:WO2007/24707,2007,A2.Locationinpatent:Page/Pagecolumn18;24

[4]Patent:US9173936,2015,B2.Locationinpatent:Page/Pagecolumn36;39;40

[5]Patent:WO2020/23680,2020,A1.Locationinpatent:Page/Pagecolumn13;78;123-124

115204-76-7

927822-41-1

[1]CurrentPatentAssignee:UROGENPHARMALTD-US9173936,2015,B2

[2]Gadd,AdamJ.R.;Castelletto,Valeria;Kabova,Elena;Shankland,Kenneth;Perrie,Yvonne;Hamley,Ian;Cobb,AlexanderJ.A.;Greco;Edwards,AlexanderD.[EuropeanJournalofPharmaceuticalSciences,2018,vol.123,p.268-276]

[3]Szekely,Thomas;Roy,Olivier;Dériaud,Edith;Job,Aurélie;Lo-Man,Richard;Leclerc,Claude;Taillefumier,Claude[JournalofMedicinalChemistry,2018,vol.61,#21,p.9568-9582]

[4]CurrentPatentAssignee:TORQUETHERAPEUTICS-WO2020/23680,2020,A1

115204-76-7

927822-42-2

[1]CurrentPatentAssignee:UROGENPHARMALTD-US9173936,2015,B2

[3]Szekely,Thomas;Roy,Olivier;Dériaud,Edith;Job,Aurélie;Lo-Man,Richard;Leclerc,Claude;Taillefumier,Claude[JournalofMedicinalChemistry,2018,vol.61,#21,p.9568-9582]

[4]CurrentPatentAssignee:TORQUETHERAPEUTICS-WO2020/23680,2020,A1

Literature

Quotation Request

Company Name:

Contact Person:

Email:

Quantity Required:

Country:

Additional Info:

SDS